Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

77 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Major clinical response to nivolumab in relapsed/refractory Hodgkin lymphoma after allogeneic stem cell transplantation.
Yared JA, Hardy N, Singh Z, Hajj S, Badros AZ, Kocoglu M, Yanovich S, Sausville EA, Ujjani C, Ruehle K, Goecke C, Landau M, Rapoport AP. Yared JA, et al. Among authors: badros az. Bone Marrow Transplant. 2016 Jun;51(6):850-2. doi: 10.1038/bmt.2015.346. Epub 2016 Feb 1. Bone Marrow Transplant. 2016. PMID: 26828905 No abstract available.
Autotransplantation for advanced lymphoma and Hodgkin's disease followed by post-transplant rituxan/GM-CSF or radiotherapy and consolidation chemotherapy.
Rapoport AP, Meisenberg B, Sarkodee-Adoo C, Fassas A, Frankel SR, Mookerjee B, Takebe N, Fenton R, Heyman M, Badros A, Kennedy A, Jacobs M, Hudes R, Ruehle K, Smith R, Kight L, Chambers S, MacFadden M, Cottler-Fox M, Chen T, Phillips G, Tricot G. Rapoport AP, et al. Bone Marrow Transplant. 2002 Feb;29(4):303-12. doi: 10.1038/sj.bmt.1703363. Bone Marrow Transplant. 2002. PMID: 11896427 Free PMC article.
Autologous stem cell transplantation followed by consolidation chemotherapy for relapsed or refractory Hodgkin's lymphoma.
Rapoport AP, Guo C, Badros A, Hakimian R, Akpek G, Kiggundu E, Meisenberg B, Mannuel H, Takebe N, Fenton R, Bolaños-Meade J, Heyman M, Gojo I, Ruehle K, Natt S, Ratterree B, Withers T, Sarkodee-Adoo C, Phillips GL, Tricot G. Rapoport AP, et al. Bone Marrow Transplant. 2004 Nov;34(10):883-90. doi: 10.1038/sj.bmt.1704661. Bone Marrow Transplant. 2004. PMID: 15517008 Clinical Trial.
Final outcomes of escalated melphalan 280 mg/m2 with amifostine cytoprotection followed autologous hematopoietic stem cell transplantation for multiple myeloma: high CR and VGPR rates do not translate into improved survival.
Hari P, Reece DE, Randhawa J, Flomenberg N, Howard DS, Badros AZ, Rapoport AP, Meisenberg BR, Filicko-Ohara J, Phillips GL, Vesole DH. Hari P, et al. Among authors: badros az. Bone Marrow Transplant. 2019 Feb;54(2):293-299. doi: 10.1038/s41409-018-0261-y. Epub 2018 Jun 15. Bone Marrow Transplant. 2019. PMID: 29907806 Clinical Trial.
Activity of single-agent melphalan 220-300 mg/m2 with amifostine cytoprotection and autologous hematopoietic stem cell support in non-Hodgkin and Hodgkin lymphoma.
Phillips GL, Meisenberg BR, Reece DE, Adams VR, Badros AZ, Brunner JL, Fenton RG, Filicko J, Grosso DL, Hale GA, Howard DS, Johnson VP, Kniska A, Marshall KW, Mookerjee B, Nath R, Rapoport AP, Sarkodee-Adoo C, Takebe N, Vesole DH, Wagner JL, Flomenberg N. Phillips GL, et al. Among authors: badros az. Bone Marrow Transplant. 2004 Apr;33(8):781-7. doi: 10.1038/sj.bmt.1704424. Bone Marrow Transplant. 2004. PMID: 14767498 Clinical Trial.
Amifostine and autologous hematopoietic stem cell support of escalating-dose melphalan: a phase I study.
Phillips GL, Meisenberg B, Reece DE, Adams VR, Badros A, Brunner J, Fenton R, Filicko J, Grosso D, Hale GA, Howard DS, Johnson VP, Kniska A, Marshall KW, Nath R, Reed E, Rapoport AP, Takebe N, Vesole DH, Wagner JL, Flomenberg N. Phillips GL, et al. Biol Blood Marrow Transplant. 2004 Jul;10(7):473-83. doi: 10.1016/j.bbmt.2004.03.001. Biol Blood Marrow Transplant. 2004. PMID: 15205668 Free article. Clinical Trial.
77 results